TY - JOUR
T1 - Validation of syndromic surveillance for respiratory pathogen activity
AU - van den Wijngaard, Cees
AU - van Asten, Liselotte
AU - van Pelt, Wilfrid
AU - Nagelkerke, Nico J D
AU - Verheij, Robert
AU - de Neeling, Albert J
AU - Dekkers, Arnold
AU - van der Sande, Marianne A B
AU - van Vliet, Hans
AU - Koopmans, Marion P G
PY - 2008/6
Y1 - 2008/6
N2 - Syndromic surveillance is increasingly used to signal unusual illness events. To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity. These syndromes showed higher levels in winter, which corresponded with higher laboratory counts of Streptococcus pneumoniae, respiratory syncytial virus, and influenza virus. Multiple linear regression models indicated that most syndrome variations (up to 86%) can be explained by counts of respiratory pathogens. Absenteeism and pharmacy syndromes might reflect nonrespiratory conditions as well. We also observed systematic syndrome elevations in the fall, which were unexplained by pathogen counts but likely reflected rhinovirus activity. Earliest syndrome elevations were observed in absenteeism data, followed by hospital data (+1 week), pharmacy/general practitioner consultations (+2 weeks), and deaths/laboratory submissions (test requests) (+3 weeks). We conclude that these syndromes can be used for respiratory syndromic surveillance, since they reflect patterns in respiratory pathogen activity.
AB - Syndromic surveillance is increasingly used to signal unusual illness events. To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity. These syndromes showed higher levels in winter, which corresponded with higher laboratory counts of Streptococcus pneumoniae, respiratory syncytial virus, and influenza virus. Multiple linear regression models indicated that most syndrome variations (up to 86%) can be explained by counts of respiratory pathogens. Absenteeism and pharmacy syndromes might reflect nonrespiratory conditions as well. We also observed systematic syndrome elevations in the fall, which were unexplained by pathogen counts but likely reflected rhinovirus activity. Earliest syndrome elevations were observed in absenteeism data, followed by hospital data (+1 week), pharmacy/general practitioner consultations (+2 weeks), and deaths/laboratory submissions (test requests) (+3 weeks). We conclude that these syndromes can be used for respiratory syndromic surveillance, since they reflect patterns in respiratory pathogen activity.
KW - Absenteeism
KW - Communicable Diseases, Emerging
KW - Family Practice
KW - Hospitalization
KW - Humans
KW - Netherlands
KW - Pharmacy
KW - Population Surveillance
KW - Registries
KW - Respiratory Tract Infections
KW - Syndrome
KW - Virus Diseases
KW - Viruses
U2 - 10.3201/eid1406.071467
DO - 10.3201/eid1406.071467
M3 - Article
C2 - 18507902
SN - 1080-6040
VL - 14
SP - 917
EP - 925
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 6
ER -